Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 USD | +0.75% | -1.44% | -5.88% |
02-12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
02-07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Business Summary
Number of employees: 32
Managers
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 31/07/21 |
Director of Finance/CFO | 52 | 01-04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 07/05/23 |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 62 | 07/05/23 |
Amresh Kumar
PRN | Corporate Officer/Principal | 44 | 14/05/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 09/10/23 |
Director/Board Member | - | 09/10/23 | |
Santosh Kottayil
BRD | Director/Board Member | - | 09/10/23 |
Chairman | 55 | 26/08/21 | |
Prashant Kohli
CEO | Chief Executive Officer | 52 | 31/07/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,404 | 7,893,546 ( 83.98 %) | 0 | 83.98 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.88% | 25.38M | |
+33.21% | 709B | |
+30.71% | 595B | |
-2.19% | 367B | |
+20.50% | 334B | |
+4.98% | 289B | |
+14.25% | 239B | |
+9.28% | 211B | |
-3.39% | 203B | |
+8.52% | 171B |
- Stock Market
- Equities
- ACST Stock
- Company Acasti Pharma Inc.